WT
EPZM

Whittier Trust’s Epizyme, Inc EPZM Stock Holding History

Whittier Trust’s Portfolio EPZM Stock Details EPZM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-30
Closed -$1K – 1627
2019
Q4 		$1K Hold
30
– – ﹤0.01% 1493
2019
Q3 		$0 Hold
30
– – ﹤0.01% 1612
2019
Q2 		$0 Hold
30
– – ﹤0.01% 1481
2019
Q1 		$0 Hold
30
– – ﹤0.01% 1526
2018
Q4 		$0 Buy
+30
New +$229 ﹤0.01% 1390
2018
Q3 		– Sell
-66
Closed -$1K – 1297
2018
Q2 		$1K Buy
+66
New +$1.03K ﹤0.01% 1251

Other funds holding EPZM

Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
RM
RP Management New York $139M AUM 37.98% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return

Whittier Trust's EPZM Position: Q1 2020 in Review

Whittier Trust sold out of Epizyme, Inc (EPZM) in Q1 2020, closing a stake of 30 shares — an estimated $1K sold.

Whittier Trust first reported a position in EPZM in Q2 2018 and held it in 6 quarters. The position peaked at $1K in Q4 2019. 143 funds tracked by Wall St. Rank hold EPZM as of Q1 2020.

  • Whittier Trust reported no remaining Epizyme, Inc position as of Q1 2020 after selling out during the quarter.
  • Whittier Trust sold 30 Epizyme, Inc shares in Q1 2020, an estimated $1K.
  • Whittier Trust first reported a position in Epizyme, Inc in Q2 2018 and held it in 6 quarters.
  • Whittier Trust's Epizyme, Inc position peaked at $1K in Q4 2019.
  • 143 funds tracked by Wall St. Rank held Epizyme, Inc as of Q1 2020.

Based on Whittier Trust's 13F filing for Q1 2020, filed 27 Apr 2020.